ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inflammatory responsive neutrophil-like membrane-based drug delivery system for post-surgical glioblastoma therapy

Chen, Huajian; Ji, Jingsen; Zhang, Li; Chen, Taoliang; Zhang, Yuxuan; Zhang, Fabing; Wang, Jihui*; Ke, Yiquan*南方医科大学
Journal of Controlled Release2023-10DOI: 10.1016/j.jconrel.2023.08.020
4阅读
引用收藏
分享

摘要

Surgical resection of glioblastoma (GBM) causes brain inflammation that activates and recruits neutrophils (NEs) to residual GBM tissues. NE-based drug delivery using inflammatory chemotaxis is promising for the post-surgical treatment of residual GBM, but its clinical application is limited by the short life span of NEs and lack of in vitro propagation methods. HL60 cells are a type of infinitely multiplying tumor cells that can be induced to differentiate into NE-like cells. We developed a novel NE-like membrane system (NM-PD) by coating NE-like membranes on the surface of poly (lactide-co-glycolide)-poly(ethylene glycol) (PLGA-PEG)-based doxorubicin (DOX)-loaded core (PLGA-PEG-DOX, PD) for post-surgical residual GBM treatment. Cell adhesion proteins were detected on NE-like membranes and endowed NM-PDs with inflammatory chemotaxis similar to mature NEs. The resulting NM-PD shows excellent inflamed in vitro blood-brain barrier (BBB) permeability and anti-proliferative effects on GBM cells. In our intracranial GBM resection model, NM-PD exhibited superior inflammatory chemotaxis and targeted residual GBM cells, thus remarkably improving antitumor capability and prolonging the survival time of the mice. These data suggest that NM-PD, which has sufficient sources and is easy to prepare, can efficiently suppress post-surgical residual GBM and holds potential for clinical transformation in GBM post-surgical adjuvant therapy.

学科与关键词

关键词
NanoparticlesInflammatoryGlioblastomaNeutrophil-like membraneBlood-brain barrier
相关
加载中…
  • Preoperative administration of a biomimetic platelet nanodrug enhances postoperative drug delivery by bypassing thrombus
    Ji, Jingsen; Lian, Weidong; Zhang, Yuxuan; Lin, Dongni; Wang, Jihui; Mo, Yunzhao; Xu, Xiangdong; Hou, Chongxian; Ma, Chengcheng; Zheng, Yaofeng; Chen, Jiawen; Zhong, Jiasheng; Zhang, Fabing*; Ke, Yiquan*; Chen, Huajian*International Journal of Pharmaceutics, 2023, 636: 122851.被引 5
  • Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo- Immunotherapy
    Zhang, Ruotian; Ye, Yicheng; Wu, Jianing; Gao, Junbin; Huang, Weichang; Qin, Hanfeng; Tian, Hao; Han, Mingyang; Zhao, Boyan; Sun, Zhenying; Chen, Xin; Dong, Xingli; Liu, Kun; Liu, Chang*; Tu, Yingfeng*; Zhao, Shiguang*ACS applied materials & interfaces, 2023, 15(14): 17627-17640.被引 4
  • Polyhedral Oligomeric Silsesquioxane-Based Nanoparticles for Efficient Chemotherapy of Glioblastoma
    Zhong, Xiangyang; Wei, Gang; Liu, Boyang; Wang, Chenyang; Wang, Juan; Lu, Yong*; Cui, Wenguo*; Guo, Hongbo*Small, 2023, 19(18).被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Controlled Release
发表日期
2023-10
卷期
第 362 卷
页码
479-488
DOI
10.1016/j.jconrel.2023.08.020
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072762, 82102750]; China Postdoctoral Science Foundation [2021M701607]; Guangzhou Science and Technology Planning Project [202102020015]

作者

  • C

    Chen, Huajian (第一作者)

    southern med univ

  • J

    Ji, Jingsen

    southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhang, Li

    southern med univ

  • C

    Chen, Taoliang

    southern med univ

  • Z

    Zhang, Yuxuan

    southern med univ

  • Z

    Zhang, Fabing

    southern med univ

  • W

    Wang, Jihui (通讯)

    southern med univ

  • K

    Ke, Yiquan (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417